Vinita Bhatt

Vinita Bhatt joined Maze Therapeutics in 2023 and currently serves as the Associate Director of Clinical Operations where she leads Maze’s first renal program in APOL1 mediated chronic kidney disease. Vinita started her career as a scientist and then later began working on the CRO side. Prior to Maze, Vinita held various clinical operations positions at sponsor companies, such as BridgeBio and BioMarin, where she focused on bringing rare disease/orphan treatments to patients.

Vinita earned a BA in Biochemistry and Molecular Biology and MA in Biotechnology from Boston University and an MS in Biomedical Sciences at Rutgers University.